Aspire Biopharma
ASBP | NASDAQ
$8.06
-$0.35 (-4.16%)
At close: Nov 16, 2026, 4:00 PM ET
$8.30
+$0.24 (+2.98%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-4.16%
(1D)No price chart data available for 1D timeframe.
Rating
29.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #813/1021 (Top 80%)
Key Statistics
Market Data
Market Cap $929.9K
1D Range
8.06 8.54
52W Range
4.65 170.40
Valuation (TTM)
PE -1
PB 0.08
EV/EBITDA N/A
Valuation (NTM)
Forward PE N/A
Forward PEG -0.01
Price Target $0.00
Cash Flow
FCF Yield -772.8%
SBC Adj. FCF Yield -789.7%
SBC Impact -2.2%
Margins
Gross Margin 18.4%
Operating Margin -7259.9%
FCF Margin -7358.2%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
100.0%
Dil EPS 3Y | 5Y 24.5% |
-42.0%
FCF 3Y | 5Y -1.1% |
-49.9%
Returns
ROA -81.6%
ROE 1993.3%
ROIC -59.8%
Financial Health
Net Cash
$12.17M
Current Ratio 7.99
Interest Coverage -0.76
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship ...
Sector Healthcare
Industry Medical - Pharmaceuticals
Employees 2
IPO Date Feb 20, 2025
Website aspirebiolabs.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove ASBP